Dynavax cuts staff in retreat from cancer research

Dynavax Technologies plans to cut 82 positions and exit cancer research, announcing Thursday a restructuring that will also involve a search for a new CEO to replace current company head Eddie Gray, who will step down after six years leading the biotech.